Walmart and Johnson & Johnson: Two “Dividend Kings” to Weather an Economic Recession Oct 7, 2025 Consumer Goods, Life Science
Supercharged Gene-Editing: Intellia’s 63% Rally Just The Start, Say Analysts Oct 7, 2025 Life Science
Is the U.S. Set for Federal Marijuana Legalization by 2026? Industry Insiders Think So Oct 5, 2025 Cannabis
Trials and Opportunities: Can UnitedHealth Reverse Its Decline with Its Financial Report? Oct 4, 2025 Life Science
Your Dividend Fortress: 2 Pharma Stocks Among 5 “Never-Sell” Picks Sep 28, 2025 Consumer Goods, Financial Service, Life Science
Pfizer’s Multi-Billion Dollar Acquisition of Metsera: A Key Move to Reshape the Weight-Loss Drug Landscape Sep 26, 2025 Life Science
Opportunities from the Dip? Analyzing Novo Nordisk’s Three Fundamental Pillars Sep 25, 2025 Life Science
